Soham A Shah1, Sophia X Cui1, Christopher D Waters1, Soichi Sano2, Ying Wang2, Heather Doviak2, Jonathan Leor3, Kenneth Walsh2, Brent A French1, Frederick H Epstein1,4. 1. Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA. 2. Hematovascular Biology Center, Robert M. Berne Cardiovascular Research Center, University of Virginia, Virginia, USA. 3. Neufield Cardiac Research Institute, Sheba Medical Center, Tel-Aviv University, Tel-Hashomer, Ramat Gan, Israel. 4. Radiology, University of Virginia, Charlottesville, Virginia, USA.
Abstract
BACKGROUND: In vivo imaging of oxidative stress can facilitate the understanding and treatment of cardiovascular diseases. We evaluated nitroxide-enhanced MRI with 3-carbamoyl-proxyl (3CP) for the detection of myocardial oxidative stress. METHODS: Three mouse models of cardiac oxidative stress were imaged, namely angiotensin II (Ang II) infusion, myocardial infarction (MI), and high-fat high-sucrose (HFHS) diet-induced obesity (DIO). For the Ang II model, mice underwent MRI at baseline and after 7 days of Ang II (n = 8) or saline infusion (n = 8). For the MI model, mice underwent MRI at baseline (n = 10) and at 1 (n = 8), 4 (n = 9), and 21 (n = 8) days after MI. For the HFHS-DIO model, mice underwent MRI at baseline (n = 20) and 18 weeks (n = 13) after diet initiation. The 3CP reduction rate, Kred , computed using a tracer kinetic model, was used as a metric of oxidative stress. Dihydroethidium (DHE) staining of tissue sections was performed on Day 1 after MI. RESULTS: For the Ang II model, Kred was higher after 7 days of Ang II versus other groups (p < 0.05). For the MI model, Kred , in the infarct region was significantly elevated on Days 1 and 4 after MI (p < 0.05), whereas Kred in the noninfarcted region did not change after MI. DHE confirmed elevated oxidative stress in the infarct zone on Day 1 after MI. After 18 weeks of HFHS diet, Kred was higher in mice after diet versus baseline (p < 0.05). CONCLUSIONS: Nitroxide-enhanced MRI noninvasively quantifies tissue oxidative stress as one component of a multiparametric preclinical MRI examination. These methods may facilitate investigations of oxidative stress in cardiovascular disease and related therapies.
BACKGROUND: In vivo imaging of oxidative stress can facilitate the understanding and treatment of cardiovascular diseases. We evaluated nitroxide-enhanced MRI with 3-carbamoyl-proxyl (3CP) for the detection of myocardial oxidative stress. METHODS: Three mouse models of cardiac oxidative stress were imaged, namely angiotensin II (Ang II) infusion, myocardial infarction (MI), and high-fat high-sucrose (HFHS) diet-induced obesity (DIO). For the Ang II model, mice underwent MRI at baseline and after 7 days of Ang II (n = 8) or saline infusion (n = 8). For the MI model, mice underwent MRI at baseline (n = 10) and at 1 (n = 8), 4 (n = 9), and 21 (n = 8) days after MI. For the HFHS-DIO model, mice underwent MRI at baseline (n = 20) and 18 weeks (n = 13) after diet initiation. The 3CP reduction rate, Kred , computed using a tracer kinetic model, was used as a metric of oxidative stress. Dihydroethidium (DHE) staining of tissue sections was performed on Day 1 after MI. RESULTS: For the Ang II model, Kred was higher after 7 days of Ang II versus other groups (p < 0.05). For the MI model, Kred , in the infarct region was significantly elevated on Days 1 and 4 after MI (p < 0.05), whereas Kred in the noninfarcted region did not change after MI. DHE confirmed elevated oxidative stress in the infarct zone on Day 1 after MI. After 18 weeks of HFHS diet, Kred was higher in mice after diet versus baseline (p < 0.05). CONCLUSIONS:Nitroxide-enhanced MRI noninvasively quantifies tissue oxidative stress as one component of a multiparametric preclinical MRI examination. These methods may facilitate investigations of oxidative stress in cardiovascular disease and related therapies.
Authors: Frederick H Epstein; Zequan Yang; Wesley D Gilson; Stuart S Berr; Christopher M Kramer; Brent A French Journal: Magn Reson Med Date: 2002-08 Impact factor: 4.668
Authors: Olivier C Manintveld; Maaike Te Lintel Hekkert; Ewout Jan van den Bos; Grietje M Suurenbroek; Dick H Dekkers; Pieter D Verdouw; Jos M Lamers; Dirk J Duncker Journal: Am J Physiol Heart Circ Physiol Date: 2006-11-22 Impact factor: 4.733
Authors: Xiaodong Zhong; Bruce S Spottiswoode; Craig H Meyer; Christopher M Kramer; Frederick H Epstein Journal: Magn Reson Med Date: 2010-10 Impact factor: 4.668
Authors: Szilard Voros; Zequan Yang; Christina M Bove; Wesley D Gilson; Frederick H Epstein; Brent A French; Stuart S Berr; Sanford P Bishop; Mark R Conaway; Hiroaki Matsubara; Robert M Carey; Christopher M Kramer Journal: Am J Physiol Heart Circ Physiol Date: 2005-10-07 Impact factor: 4.733
Authors: Periannan Kuppusamy; Haiquan Li; Govindasamy Ilangovan; Arturo J Cardounel; Jay L Zweier; Kenichi Yamada; Murali C Krishna; James B Mitchell Journal: Cancer Res Date: 2002-01-01 Impact factor: 12.701
Authors: C Feillet-Coudray; T Sutra; G Fouret; J Ramos; C Wrutniak-Cabello; G Cabello; J P Cristol; C Coudray Journal: Free Radic Biol Med Date: 2008-12-10 Impact factor: 7.376
Authors: Euy-Myoung Jeong; Man Liu; Megan Sturdy; Ge Gao; Susan T Varghese; Ali A Sovari; Samuel C Dudley Journal: J Mol Cell Cardiol Date: 2011-09-25 Impact factor: 5.000